EP3684382A4 - Amnion tissue preparations and methods of using - Google Patents

Amnion tissue preparations and methods of using Download PDF

Info

Publication number
EP3684382A4
EP3684382A4 EP18859483.2A EP18859483A EP3684382A4 EP 3684382 A4 EP3684382 A4 EP 3684382A4 EP 18859483 A EP18859483 A EP 18859483A EP 3684382 A4 EP3684382 A4 EP 3684382A4
Authority
EP
European Patent Office
Prior art keywords
methods
tissue preparations
amnion tissue
amnion
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP18859483.2A
Other languages
German (de)
French (fr)
Other versions
EP3684382A1 (en
Inventor
Gary M. Petrucci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/708,413 external-priority patent/US10251917B1/en
Priority claimed from US15/708,425 external-priority patent/US20190083547A1/en
Application filed by Individual filed Critical Individual
Publication of EP3684382A1 publication Critical patent/EP3684382A1/en
Publication of EP3684382A4 publication Critical patent/EP3684382A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
EP18859483.2A 2017-09-19 2018-09-19 Amnion tissue preparations and methods of using Pending EP3684382A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15/708,413 US10251917B1 (en) 2017-09-19 2017-09-19 Methods and materials for treating tumors
US15/708,425 US20190083547A1 (en) 2017-09-19 2017-09-19 Transdermal delivery of amnion tissue preparations
PCT/US2018/051651 WO2019060355A1 (en) 2017-09-19 2018-09-19 Amnion tissue preparations and methods of using

Publications (2)

Publication Number Publication Date
EP3684382A1 EP3684382A1 (en) 2020-07-29
EP3684382A4 true EP3684382A4 (en) 2021-06-09

Family

ID=65809869

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18859483.2A Pending EP3684382A4 (en) 2017-09-19 2018-09-19 Amnion tissue preparations and methods of using

Country Status (3)

Country Link
EP (1) EP3684382A4 (en)
CA (1) CA3076485A1 (en)
WO (1) WO2019060355A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612028A (en) * 1988-02-17 1997-03-18 Genethics Limited Method of regenerating or replacing cartilage tissue using amniotic cells
US20100124569A1 (en) * 2008-11-19 2010-05-20 Abbot Stewart Amnion derived adherent cells
US20150335686A1 (en) * 2014-05-21 2015-11-26 Mimedx Group, Inc. Micronized wharton's jelly
US20160199417A1 (en) * 2014-06-15 2016-07-14 Amnio Technology Llc Method of treatment utilizing an acellular amnion derived therapeutic composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120171180A1 (en) * 2010-12-30 2012-07-05 Sascha Abramson Compositions comprising amnion derived adherent cells and platelet-rich plasma
US8961617B2 (en) * 2012-03-08 2015-02-24 Liventa Bioscience, Inc. Amnion and chorion constructs and uses thereof in abdominal surgery
EP3185918B1 (en) * 2014-08-28 2021-08-18 MiMedx Group, Inc. Collagen reinforced tissue grafts
US9238090B1 (en) * 2014-12-24 2016-01-19 Fettech, Llc Tissue-based compositions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612028A (en) * 1988-02-17 1997-03-18 Genethics Limited Method of regenerating or replacing cartilage tissue using amniotic cells
US20100124569A1 (en) * 2008-11-19 2010-05-20 Abbot Stewart Amnion derived adherent cells
US20150335686A1 (en) * 2014-05-21 2015-11-26 Mimedx Group, Inc. Micronized wharton's jelly
US20160199417A1 (en) * 2014-06-15 2016-07-14 Amnio Technology Llc Method of treatment utilizing an acellular amnion derived therapeutic composition

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SARALIDZE ET AL: "New acrylic microspheres for arterial embolization: Combining radiopacity for precise localization with immobilized thrombin to trigger local blood coagulation", BIOMATERIALS, ELSEVIER, AMSTERDAM, NL, vol. 28, no. 15, 13 March 2007 (2007-03-13), pages 2457 - 2464, XP005919506, ISSN: 0142-9612, DOI: 10.1016/J.BIOMATERIALS.2006.12.031 *
See also references of WO2019060355A1 *

Also Published As

Publication number Publication date
EP3684382A1 (en) 2020-07-29
WO2019060355A1 (en) 2019-03-28
CA3076485A1 (en) 2019-03-28

Similar Documents

Publication Publication Date Title
EP3694529A4 (en) Trispecific proteins and methods of use
EP3399902A4 (en) One-operator surgical system and methods of use
EP3595699A4 (en) Cartilage-homing peptide conjugates and methods of use thereof
EP3624773A4 (en) Ophthalmic compositions and methods of use
EP3442515A4 (en) Liposomal preparation and methods of treatment
EP3638290A4 (en) Renal-homing peptide conjugates and methods of use thereof
EP3728323A4 (en) Anti-frizzled antibodies and methods of use
EP3752166A4 (en) Trialkyne linking agents and methods of use
EP3638331A4 (en) Three dimensional tissue compositions and methods of use
EP3679577A4 (en) Hla tissue matching and methods therefor
EP3784148A4 (en) Implants and methods of use and assembly
EP3576764A4 (en) Kras peptide vaccine compositions and method of use
EP3870203A4 (en) Therapeutic combinations of tdfrps and additional agents and methods of use
EP3678701A4 (en) Therapeutic protein compositions and methods of making and using the same
EP3635000A4 (en) Manabodies and methods of using
EP3891175A4 (en) Modified proteins and associated methods of treatment
EP3710589A4 (en) Anti-c1s antibodies and methods of use
EP3684819A4 (en) Anti-ykl40 antibodies and methods of use
EP3713583A4 (en) Methods and compositions for treatment of skin
EP3826652A4 (en) Hepato-biliary-pancreatic tissues and methods of making same
EP3534953A4 (en) Human zika virus antibodies and methods of use therefor
EP3758633A4 (en) Implants and methods of use and assembly
EP3423064A4 (en) Formulations of testosterone and methods of treatment therewith
EP3749691A4 (en) Angptl8-binding agents and methods of use thereof
EP3642231A4 (en) Anti-vista antibodies and methods of use

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200325

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20210507

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 35/12 20150101AFI20210430BHEP

Ipc: A61K 35/48 20150101ALI20210430BHEP

Ipc: A61K 35/50 20150101ALI20210430BHEP

Ipc: A61K 9/00 20060101ALI20210430BHEP

Ipc: A61K 9/16 20060101ALI20210430BHEP